Skip to main content

GOLDMAN SACHS GROUP INC

Position in NMRA — Neumora Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in NMRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$516,564
-$591,581 QoQ
Shares Held
303,862
-46.5% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 111 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in NMRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. NMRA ranks #284 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NMRA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $516,564 303,862
2026-03-31 $1,108,145 568,280
2025-12-31 $1,536,717 858,502
2025-09-30 $686,820 377,374
2025-06-30 $368,089 502,169
2025-03-31 $607,784 607,784
2024-12-31 $6,793,783 640,923
2024-09-30 $4,491,676 340,021
2024-06-30 $3,130,431 318,457
2024-03-31 $2,235,461 162,579
2023-12-31 $10,100,795 592,422
2023-09-30 $1,038,496 73,600